ESR1 and breast carcinoma: Taken together, these results demonstrate that IGF-IR reduces the aggressiveness of ERα-positive breast cancer cells and suggest that the protective role of IGF-IR and/or its cross-talk with ERα in these cells is lost in ERα-suppressed breast cancer cells.